Organic compounds

Details for Australian Patent Application No. 2006211205 (hide)

Owner Novartis AG

Inventors Earnest, David Lewis; Rojavin, Mikhail; Tougas, Gervais

Agent Davies Collison Cave

Pub. Number AU-A-2006211205

PCT Pub. Number WO2006/083710

Priority 60/648,479 31.01.05 US

Filing date 27 January 2006

Wipo publication date 10 August 2006

International Classifications

A61K 31/4045 (2006.01)

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 31/4439 (2006.01)

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

26 July 2007 PCT application entered the National Phase

  PCT publication WO2006/083710 Priority application(s): WO2006/083710

18 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006211216-Purification process for plasmid DNA

2006211197-Color control of a web printing press utilizing intra-image color measurements